Lori Capone

1.2k total citations
13 papers, 1.0k citations indexed

About

Lori Capone is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Lori Capone has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in Lori Capone's work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Lori Capone is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Lori Capone collaborates with scholars based in Switzerland, United States and Israel. Lori Capone's co-authors include Peter Schäfer, Anastasia Parton, Hon‐Wah Man, George W. Muller, Rajesh Chopra, David Stirling, Jilly F. Evans, Helen Brady, Amos Gilhar and Miles D. Houslay and has published in prestigious journals such as Blood, The Journal of Immunology and British Journal of Pharmacology.

In The Last Decade

Lori Capone

13 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Capone Switzerland 9 466 399 307 179 162 13 1.0k
Anastasia Parton Switzerland 10 442 0.9× 260 0.7× 345 1.1× 231 1.3× 79 0.5× 16 843
Fusako Nishigaki Japan 19 469 1.0× 141 0.4× 73 0.2× 183 1.0× 208 1.3× 41 1.0k
Michael Friedman United States 7 113 0.2× 103 0.3× 71 0.2× 141 0.8× 132 0.8× 8 564
Yuning Liao China 25 1.1k 2.5× 108 0.3× 70 0.2× 455 2.5× 70 0.4× 58 1.6k
Masamichi Inami Japan 17 331 0.7× 472 1.2× 37 0.1× 173 1.0× 81 0.5× 41 1.0k
Basharut A. Syed United Kingdom 15 250 0.5× 88 0.2× 152 0.5× 77 0.4× 73 0.5× 24 678
Yvonne Sun United States 7 309 0.7× 238 0.6× 42 0.1× 141 0.8× 44 0.3× 7 631
Marianne Scheel Fjording Denmark 11 303 0.7× 238 0.6× 29 0.1× 125 0.7× 45 0.3× 17 610
Prince George United States 6 945 2.0× 162 0.4× 231 0.8× 142 0.8× 34 0.2× 9 1.2k
Quin Van United States 14 612 1.3× 226 0.6× 192 0.6× 390 2.2× 27 0.2× 24 1.1k

Countries citing papers authored by Lori Capone

Since Specialization
Citations

This map shows the geographic impact of Lori Capone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Capone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Capone more than expected).

Fields of papers citing papers by Lori Capone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Capone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Capone. The network helps show where Lori Capone may publish in the future.

Co-authorship network of co-authors of Lori Capone

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Capone. A scholar is included among the top collaborators of Lori Capone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Capone. Lori Capone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Schäfer, Peter, Alan Kivitz, Jianglin Ma, et al.. (2019). Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study. Rheumatology and Therapy. 7(1). 101–119. 45 indexed citations
2.
Nakayama, Yumi, Jolanta Kosek, Lori Capone, et al.. (2017). Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity. The Journal of Immunology. 199(7). 2388–2407. 39 indexed citations
3.
4.
Schäfer, Peter, Anastasia Parton, Lori Capone, et al.. (2014). Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cellular Signalling. 26(9). 2016–2029. 248 indexed citations
5.
Ruchelman, Alexander L., Hon‐Wah Man, Weihong Zhang, et al.. (2012). Isosteric analogs of lenalidomide and pomalidomide: Synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 23(1). 360–365. 50 indexed citations
6.
Hoffmann, Matthew, Claudia Kasserra, Peter Schäfer, et al.. (2012). Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration. Cancer Chemotherapy and Pharmacology. 71(2). 489–501. 98 indexed citations
7.
Schäfer, Peter, Emily Rychak, Derek Mendy, et al.. (2012). Targeting Cereblon with the High Affinity Immunomodulatory Compound CC-220: A Novel Therapeutic Agent for B Cell Dyscrasias. Blood. 120(21). 1055–1055. 1 indexed citations
8.
Gandhi, Anita K., Derek Mendy, Anastasia Parton, et al.. (2012). CC-122 Is a Novel Pleiotropic Pathway Modifier with Potent in Vitro Immunomodulatory and Anti-Angiogenic Properties and in Vivo Anti-Tumor Activity in Hematological Cancers.. Blood. 120(21). 2963–2963. 8 indexed citations
9.
Hoffmann, Matthew, Gondi Kumar, Peter Schäfer, et al.. (2011). Disposition, metabolism and mass balance of [14C]apremilast following oral administration. Xenobiotica. 41(12). 1063–1075. 41 indexed citations
10.
Gandhi, Anita K., Lori Capone, Anastasia Parton, et al.. (2010). Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function. Current Cancer Drug Targets. 10(2). 155–167. 142 indexed citations
11.
Parton, Andrew, Ajeet Kumar Gandhi, Lori Capone, et al.. (2009). Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis. British Journal of Pharmacology. 159(4). 842–855. 328 indexed citations
12.
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasia Parton Breakdown of academic impact, for papers by Fusako Nishigaki Breakdown of academic impact, for papers by Michael Friedman Breakdown of academic impact, for papers by Yuning Liao Breakdown of academic impact, for papers by Masamichi Inami Breakdown of academic impact, for papers by Basharut A. Syed Breakdown of academic impact, for papers by Yvonne Sun Breakdown of academic impact, for papers by Marianne Scheel Fjording Breakdown of academic impact, for papers by Prince George Breakdown of academic impact, for papers by Quin Van
Rankless by CCL
2026